News

U.S. stocks closed higher Friday, capping a choppy week of trading with the market's third winning week in the last four and ...
NasdaqGS:GILD 1 Year Share Price vs Fair Value Explore Gilead Sciences's Fair Values from the Community and ...
We recently published 10 Stocks with Eye-Popping Gains; 5 Jump to New Highs. Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best-performing stocks on Friday. Gilead Sciences jumped to a new ...
Gilead Sciences Inc. (NASDAQ:GILD) is one of the most undervalued quality stocks to buy according to hedge funds. On July 25, the European Medicines Agency’s Committee for Medicinal Products for Human ...
The Dow Jones Industrial Average rose 259.17 points, or 0.59%, to 44,227.81, the S&P 500 gained 52.39 points, or 0.83%, to 6,392.39 and the Nasdaq Composite gained 200.15 points, or 0.94%, to ...
The TSX Composite Index recovered 56.26 points by noon EDT Friday to 27,817.53. In a holiday-shortened week, the index climbed 797 points, or 2.95%. The Canadian dollar dipped 0.11 cents to 72.70 ...
Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.
In a report released today, Joseph Stringer from Needham maintained a Buy rating on Cidara Therapeutics, with a price target of $74.00. The company’s shares closed yesterday at $61.73. Take advantage ...